| mycobacterium branderi sp. nov., a new potential human pathogen. | a number of mycobacterial strains with similar growth characteristics, metabolic properties, and lipid compositions, which were previously placed in the helsinki group (e. brander, e. jantzen, r. huttunen, a. juntunen, and m.-l. katila, j. clin. microbiol. 30:1972-1975, 1992), were characterized by performing 16s rrna gene sequencing. of the 14 strains studied, 9 had a unique, previously undescribed sequence in the variable region of 16s rrna. these nine strains, all of which were isolated from ... | 1995 | 8590682 |
| gas-chromatographic lipid profiles in identification of currently known slowly growing environmental mycobacteria. | cellular fatty acid analysis by glc is widely used in the species identification of mycobacteria. combining mycolic acid cleavage products with shorter cellular fatty acids increases the informative value of the analysis. a key has been created to aid in the identification of all currently known slowly growing environmental species. in this scheme, the species are classified into six categories, each characterized by a combination of fatty markers shared by those species. within each category, i ... | 2003 | 12676870 |
| [a case of pulmonary nontuberculous mycobacteriosis caused by mycobacterium branderi]. | the patient was a 56-year-old man, who was found to have a cavitary lesion surrounded by small nodules in the left upper lobe (s(1+2)) on the chest computed tomography (ct) scan prior to surgery for oropharyngeal cancer. both sputum and bronchial lavage smears for acid-fast bacilli were positive, but a polymerase chain reaction for mycobacterium tuberculosis and mycobacterium avium complex failed to identify the isolates. mycobacterium species were cultured in 4 weeks. mycobacterium branderi was ... | 2014 | 25095645 |
| mycobacterium kyorinense sp. nov., a novel, slow-growing species, related to mycobacterium celatum, isolated from human clinical specimens. | a novel, non-pigmented, slow-growing mycobacterium was identified on the basis of biochemical and nucleic acid analyses, as well as growth characteristics. three isolates were cultured from clinical samples (two from sputum and one from pus in lymph nodes) obtained from three immunocompetent patients with infections. bacterial growth occurred at 28-42 degrees c on middlebrook 7h11-oadc agar. the isolates showed negative results for tween hydrolysis, nitrate reductase, semiquantitative catalase, ... | 2009 | 19502312 |
| mycobacterium branderi isolated from pus of a right pulmonary cavitary lesion. | | 2005 | 15973015 |
| mycobacterium branderi from both a hand infection and a case of pulmonary disease. | mycobacterium branderi, a potential human pathogen first characterized in 1995, has been isolated from respiratory tract specimens. we report here a case in which m. branderi was the only organism isolated upon culture from a hand infection. this isolate, along with a second isolate from a bronchial specimen, was subjected to conventional identification tests for mycobacterial species. further analysis by high-performance liquid chromatography (hplc) of mycolic acids and 16s rrna gene sequencing ... | 2000 | 11015432 |
| drug susceptibility of 33 reference strains of slowly growing mycobacteria to 19 antimicrobial agents. | objectives. slowly growing mycobacteria (sgm) are prevalent worldwide and cause an extensive spectrum of diseases. methods. in this study, the antimicrobial susceptibility of 33 reference strains of sgm to 19 antimicrobial agents was tested using a modified microdilution method. results. cefmetazole (32/33) and azithromycin (32/33) exhibited the highest antimicrobial activity, and dapsone (9/33) exhibited the lowest activity against the tested strains. cefoxitin (30/33), cefoperazone (28/33), an ... | 2017 | 28512635 |
| mycobacterium branderi infection: case report and literature review of an unusual and difficult-to-treat non-tuberculous mycobacterium. | a 67-year-old man with significant smoking history presented with fever, unintentional weight loss, night sweats, productive cough, and progressive dyspnea. multiple respiratory specimens grew mycobacterium branderi. computed tomography scanning of the chest revealed a cavitary right upper lung lesion. bronchoscopy and thoracoscopic biopsy were negative for malignancy but showed necrotizing granulomatous inflammation, which was culture negative. due to clinical and radiologic progression despite ... | 2017 | 28268125 |
| isolation of mycobacterium branderi, an unusual species from an acute myelogenous leukemia patient. | we report a case of pulmonary infection caused by mycobacterium branderi, a slow growing non-tuberculosis mycobacteria, in a patient with acute myelogenous leukemia. the pulmonary disease was treated successfully with the combination of ciprofloxacin, doxycycline and clarithromycin. m. branderi may be considered as an opportunistic pathogen, especially among immunologically compromised patients. | 2014 | 24678467 |
| first isolation of mycobacterium kyorinense from clinical specimens in brazil. | in this article, the first isolation of mycobacterium kyorinense specimens in brazil is described. m. kyorinense is a recently identified species, with a few strains reported only in japan. the brazilian isolates were initially identified as mycobacterium celatum by pcr restriction enzyme pattern analysis (pra) with hsp65. however, biochemical tests indicated the same profile of m. kyorinense and distinguished them from m. celatum and mycobacterium branderi. the sequencing of the hsp65, rpob, an ... | 2012 | 22518856 |